New tablet study: absorption and food effects
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests a new form of the drug nurandociguat tablet to see how well it is absorbed compared to the old tablet, and whether food changes how it works. Healthy volunteers are needed to take the tablets and have their blood levels checked.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 58 years old.
- You must be in good general health (no major medical problems).
- Your body mass index (BMI) should be between 18 and 29.9.
- You must weigh at least 132 pounds (60 kg).
- You cannot be on any regular medications or have had diarrhea or constipation in the last 2 weeks.
- You must be willing to eat the meals provided during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a single dose of an investigational medicine (NNC0537-1482) to see how it moves through the body in people with different levels of kidney function. It may help researchers understand how the drug is processed so it can be dosed safely in future studies.
This study tests a new medicine, SAL0140, at different doses to see if it can help people with chronic kidney disease. It may reduce protein in the urine, which is a sign of kidney damage.
This trial tests a medication called EC5026 in people with and without chronic kidney disease (CKD) to see how the body handles it. It helps understand if dose adjustments are needed for people with impaired kidney function.
This study tests whether a new drug called nurandociguat, when taken with nitroglycerin, is safe and how it affects the body in people with coronary artery disease. It may help improve treatment options for this condition.
This trial tests a new tablet drug in healthy people to see how safe it is and how the body processes it. It is an early-stage study, meaning it helps find the right dose and check for side effects.
This study tests a new tablet in healthy adults to see how the body processes it and whether food changes its effects. It helps determine the right dose and safety for future patients.
Hear when a new Chronic kidney disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.